Edwards Lifesciences (LTS:0REN) Marketable Securities : CHF420 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Edwards Lifesciences's Marketable Securities for the quarter that ended in Mar. 2024 was CHF420 Mil.

Edwards Lifesciences's annual Marketable Securities declined from Dec. 2021 (CHF556 Mil) to Dec. 2022 (CHF416 Mil) but then increased from Dec. 2022 (CHF416 Mil) to Dec. 2023 (CHF433 Mil).

Edwards Lifesciences Marketable Securities Historical Data

The historical data trend for Edwards Lifesciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Marketable Securities Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

331.92

194.92

556.28

415.77

432.83

Edwards Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															353.26	420.22	408.24	432.83	420.31

Edwards Lifesciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Edwards Lifesciences (LTS:0REN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Edwards Lifesciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (LTS:0REN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil EWLS:Austria

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines